Revon Media
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us
No Result
View All Result
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us
No Result
View All Result
Revon Media
No Result
View All Result

Duopharma’s high productivity amidst innovation focus

A blockchain advantage
Share on FacebookShare on Twitter

Duopharma Biotech Berhad (Duopharma Biotech) is strengthening its position as a leading pharmaceutical and healthcare company in Malaysia.

It is also a commitment to maintaining its leading position as an innovative pharmaceutical company in the country and a global leader in the halal sector. In addition, its intensified focus on Environmental, Social and Governance (ESG) has made the Group a preferred employer, trusted partner, attractive investment and an increasingly strong brand.

The Group ended 2021 with a stellar five-year record performance, posting revenue of RM639.18 million and a record profit before tax (PBT) of RM82.98 million, amounting to a nine per cent increase from the previous year. Subsequently, the Group started 2022 on a promising note with commendable first quarter 2022 results, as PBT climbed 15 per cent to RM26.65 million, on the back of a 12 per cent higher revenue of RM185.94 million.

At its recent 21st Annual General Meeting (AGM) Duopharma Biotech Chairman Tan Sri Siti Sa’diah Sh Bakir commented: “In 2021, we continued to hold the wellbeing of all employees and stakeholders as our top priority. To keep them safe from Covid-19, we enhanced all pandemic-related standard operating procedures at our plants and maintained split operations at our offices.”

As the global focus on sustainability intensified in recent years, the Group is redoubling its efforts as a responsible corporate citizen by further strengthening its ESG platform. Duopharma Biotech has committed to carbon neutrality by 2030 and net zero emissions by 2050.

In 2021, the Group began developing a five-year ESG Strategy (2022-2026), and in March 2022, Duopharma Biotech announced its environmental pledge in conjunction with its ESG roadmap. The initiatives related to the ESG Strategy will commence this year onwards

Duopharma Biotech Group Managing Director Leonard Ariff Abdul Shatar said: “Looking back, we are pleased that early actions have allowed the Group to navigate the pandemic relatively unscathed. We initiated our emergency response preparations before the pandemic was first declared, and we have managed to maintain a high level of productivity amid the movement restrictions and plant upgrades.”

Leonard Ariff said the Group will focus more on digitalising Duopharma Biotech. As part of the efforts, a Digital Health Strategy has been crafted to identify opportunities that will allow the Group to provide the best solutions along the healthcare value chain.

He added that as part of the plan to expand through multiple avenues, including mergers and acquisitions, the Group has identified and evaluated a number of local and international companies. — The Health

Tags: Duopharma BiotechESGLocal NewsPharmaceutical companyThe Health 2022The Health July/Aug 2022theHealth
Previous Post

IJN addresses medication non-adherence

Next Post

IHH to gain RM902m from IMU sale

Live Edition Paper

NOV 2020 ePaper

OCT 2020 ePaper


 

Subscribe for free complimentary live editions:

Recent News

  • Moderna’s Covid-19 shots for kids under six
    June 29, 2022
    MODERNA’S Covid-19 vaccine works in babies, toddlers and preschoolers, the […]
  • Not a miracle drug
    October 21, 2021
    Ivermectin should not be regarded as a wonder drug against Covid-19 under any […]
  • Malaysian-American’s free offer to the world
    October 6, 2021
    A Malaysian-American mechanical engineer, Guruthisvaran Ramu, has offered to […]
  • GenScript’s state-of-art manufacturing facility in Singapore
    April 28, 2022
    GenScript Biotech Corporation (GenScript), the world’s leading life science […]
  • A platform for professional service
    December 21, 2022
    Optometrists want to be a means where the public can refer to and obtain […]

Connect

Office

Revon Media Sdn Bhd
A member of Revongen Corporation
Headquarters
Revongen Corporation Center,
Level 17, Top Glove Tower, No.16,
Persiaran Setia Dagang,Setia Alam,
Seksyen U13, 40170 Shah Alam,
Selangor Darul Ehsan, Malaysia.

Contact

Tel: +603 3359 1166
Fax: +6 03 3358 0303

Copyright © 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd. About Us | Contact Us | Privacy Policy | Terms of use

No Result
View All Result
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us

© 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist